Sonja Hjellegjerde Brunvoll

  • Researcher; PhD
 

Publications 2024

Buer S, Hagen BI, Søraas A, White RA, Bø R, Ellingjord-Dale M, Istre MS, Brunvoll SH, Lerdal A, Landrø NI, Nygaard AB, Stubberud J (2024)
Executive deficits after SARS-CoV-2 infection: A cross-sectional population study
Brain Behav Immun Health, 41, 100857
DOI 10.1016/j.bbih.2024.100857, PubMed 39314761

Ellingjord-Dale M, Brunvoll SH, Søraas A (2024)
Prospective Memory Assessment before and after Covid-19
N Engl J Med, 390 (9), 863-865
DOI 10.1056/NEJMc2311200, PubMed 38416436

Ellingjord-Dale M, Nygaard AB, Støer NC, Bø R, Landrø NI, Brunvoll SH, Istre M, Kalleberg KT, Dahl JA, Geng L, Tsilidis K, Riboli E, Ursin G, Søraas A (2024)
Temporal trajectories of long-COVID symptoms in adults with 22 months follow-up in a prospective cohort study in Norway
Int J Infect Dis, 107263 (in press)
DOI 10.1016/j.ijid.2024.107263, PubMed 39419167

Holland P, Istre M, Ali MM, Gedde-Dahl T, Buechner J, Wildhagen M, Brunvoll SH, Horvath S, Matsuyama S, Dahl JA, Stölzel F, Søraas A (2024)
Epigenetic aging of human blood cells is influenced by the age of the host body
Aging Cell, 23 (5), e14112
DOI 10.1111/acel.14112, PubMed 38439206

Søraas A, Brunvoll SH, Nygaard AB, Dahl JA, Ursin G (2024)
Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan
Lancet, 403 (10434), 1336
DOI 10.1016/S0140-6736(24)00414-8, PubMed 38582558

Publications 2022

Brunvoll SH, Flote VG, Halset EH, Bertheussen GF, Skjerven H, Lømo J, Thune I, Hjartåker A (2022)
Normal and unusual days for dietary intake during the 12 months after a breast cancer diagnosis in women
Eur J Nutr, 61 (8), 3873-3885
DOI 10.1007/s00394-022-02925-9, PubMed 35750881

Brunvoll SH, Nygaard AB, Ellingjord-Dale M, Holland P, Istre MS, Kalleberg KT, Søraas CL, Holven KB, Ulven SM, Hjartåker A, Haider T, Lund-Johansen F, Dahl JA, Meyer HE, Søraas A (2022)
Prevention of covid-19 and other acute respiratory infections with cod liver oil supplementation, a low dose vitamin D supplement: quadruple blinded, randomised placebo controlled trial
BMJ, 378, e071245
DOI 10.1136/bmj-2022-071245, PubMed 36215222

Brunvoll SH, Nygaard AB, Fagerland MW, Holland P, Ellingjord-Dale M, Dahl JA, Søraas A (2022)
Post-acute symptoms 3-15 months after COVID-19 among unvaccinated and vaccinated individuals with a breakthrough infection
Int J Infect Dis, 126, 10-13
DOI 10.1016/j.ijid.2022.11.009, PubMed 36375693

Ellingjord-Dale M, Kalleberg KT, Istre MS, Nygaard AB, Brunvoll SH, Eggesbø LM, Dahl JA, Kjetland EF, Ursin G, Søraas A (2022)
The use of public transport and contraction of SARS-CoV-2 in a large prospective cohort in Norway
BMC Infect Dis, 22 (1), 252
DOI 10.1186/s12879-022-07233-5, PubMed 35287611

Publications 2021

Bøhn SK, Thune I, Flote VG, Frydenberg H, Bertheussen GF, Husøy A, Fjeldheim F, Brunvoll SH, Hjartåker A, Mowinckel MC, Sandset PM, Iversen PO (2021)
Effects of a 1-Year Physical Activity Intervention on Markers of Hemostasis among Breast Cancer Survivors: A Randomized Controlled Trial
TH Open, 5 (1), e14-e23
DOI 10.1055/s-0040-1721782, PubMed 33564742

Publications 2020

Brunvoll SH, Thune I, Bertheussen GF, Fjeldheim F, Flote VG, Frydenberg H, Lundgren S, Skjerven H, Lømo J, Fagerland MW, McTiernan A, Schlichting E, Hjartåker A (2020)
Dietary changes in early-stage breast cancer patients from pre-surgery and over the 12 months post-surgery
Br J Nutr, 125 (2), 172-182
DOI 10.1017/S0007114520002627, PubMed 32811572

Publications 2018

Brunvoll SH, Thune I, Frydenberg H, Flote VG, Bertheussen GF, Schlichting E, Bjerve KS, Hjartåker A (2018)
Validation of repeated self-reported n-3 PUFA intake using serum phospholipid fatty acids as a biomarker in breast cancer patients during treatment
Nutr J, 17 (1), 94
DOI 10.1186/s12937-018-0402-6, PubMed 30333016